Modern Vaccines Adjuvants & Delivery Systems

12-14 September 2017, Crowne Plaza Hotel, Porto, Portugal

  • Increase font size
  • Default font size
  • Decrease font size


Join the conversation on Twitter – #MVADS2017

The drive for the new generation of vaccine therapies has precipitated a concurrent need for new and improved adjuvantation/delivery systems for these new vaccines. This new international conference will focus on updating the community on new adjuvant/delivery systems/technologies associated with developing modern vaccines strategies and vaccine research. There is now an urgent need for the development of these potent and safe adjuvants and delivery systems and MVADS 2017 will offer researchers a fresh forum to discuss this important topic in detail.

MVADS 2017 will be of interest to researchers/contributors from academic programs, industrial, governmental and regulatory groups.

Advisory Scientific Panel

Edmond J. Remarque (BPRC, Rijswijk, The Netherlands)
Dennis Christensen (Statens Serum Institut, Copenhagen, Denmark)
Erik Lindblad (Brenntag Biosector, Copenhagen, Denmark)
Manmohan Singh (Takeda Vaccines Inc., Cambridge, Massachusetts, USA)
Heather Davis (Seqirus, Maidenhead, Berkshire, UK)
Derek O’Hagan (GSK, Rockville, Maryland, USA)
Adriana Baz Morelli (CSL Ltd, Melbourne, Australia)
Nathalie Garcon (BIOASTER Technology Research Institute, Lyon, France)
Niranjan Sardesai (Inovio Pharmaceuticals, Blue Bell, Pennsylvania, USA)
Virgil Schijns (Wageningen Unviversity, The Netherlands)
Gary Ott (Dynavax Inc., San Diego, California, USA)
Burkhard Becher (University of Zurich, Zurich, Switzerland)
Maria Lazaro (SEPPIC, Paris, France)
Geert Vanden Bossche (UNIVAC LLC, Belgium)
Chris Fox (IDRI, Seattle, USA)
Martin Bachmann (Inselspital, Bern, Switzerland / University of Oxford, Oxford, UK)
Anna-Karin Maltais (Eurocine Vaccines AB, Solna, Sweden)
Stefan Jungbluth (EVI, Heidelberg, Germany)
Jeffrey A. Hubbell (University of Chicago, Chicago, Illinois, USA)
Behazine Combadiere (Cimi-Paris, Paris, France)
Ken Ishii (NIBIOHN/University of Osako, Osako, Japan)
Ofer Levy (Boston Children's Hospital/Harvard Medical School, Boston, Massachusetts, USA)
Jean Haensler (Sanofi Pasteur, Marcy L'Etoile, France)

Conference Scope

Scientific Sessions:

  • Mechanistic Interpretations
  • Delivery
  • Formulation & Design
  • Modern Vaccines & Adjuvants
  • Safety
  • Regulation
  • Future Developments

MVADS 2017 Delegates

Login details will be supplied after you have registered for the event.

MVADS 2017 Sponsors

  • Novavax
  • Eurocine Vaccines
  • BPRC
  • Inovio
  • Pfizer
  • Matrivax
  • Mucosis
  • Precision Vaccines Program
  • BIA Separations
  • Aldevron
  • Sanofi Pasteur
  • Janssen
  • iZon Science
  • EVI
  • Univac
  • Bill and Melinda Gates Foundation
  • Brenntag
  • Seppic
  • BioAster
  • VisMederi
  • National Institute of Allergy and Infectious Diseases
  • Vaxart
  • CureVac
  • IDRI
  • Mymetics

MVADS 2017 Downloads

MVADS 2017 Leaflet

MVADS 2017 Mailing List

E-mail Address
What is 3+2-1?